Azithromycin inhibits the formation of flagellar filaments without suppressing flagellin synthesis in Salmonella enterica serovar typhimurium

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 8, 2005, Pages 3396-3403

  Matsui, Hidenori ^a,b   Eguchi, Masahiro ^a,b   Ohsumi, Katsufumi ^b   Nakamura, Akio ^c   Isshiki, Yasunori ^b,d   Sekiya, Kachiko ^a   Kikuchi, Yuji ^a   Nagamitsu, Tohru ^a   Masuma, Rokuro ^a,b   Sunazuka, Toshiaki ^a,b   Omura, Satoshi ^a,b  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO INSTITUTE   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d JOSAI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CHLORAMPHENICOL; CLARITHROMYCIN; ERYTHROMYCIN; ERYTHROMYCIN RIBOSOME METHYLASE; FLAGELLIN; MACROLIDE; METHYLTRANSFERASE; NALIDIXIC ACID; ROKITAMYCIN; ROXITHROMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL FLAGELLUM; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFICACY; ELECTRON MICROSCOPY; ERMBC GENE; FEMALE; IMMUNOBLOTTING; IN VITRO STUDY; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SALMONELLA ENTERICA; SALMONELLOSIS; TREATMENT FAILURE;

ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CELL LINE; EPITHELIAL CELLS; FEMALE; FLAGELLA; FLAGELLIN; HUMANS; INTESTINES; MACROPHAGES; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MOVEMENT; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM;

EID: 23044460323     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.8.3396-3403.2005     Document Type: Article

References (56)

1. Ahmer, B. M. 2004. Cell-to-cell signaling in Escherichia coli and Salmonella enierica. Mol. Microbiol. 52:933-945.
2. Berg, H. C. 2003. The rotary motor of bacterial flagella. Annu. Rev. Biochem. 72:19-54.
3. Brisson-Noel, A., M. Arthur, and P. Courvalin. 1988. Evidence for natural gene transfer from gram-positive cocci to Escherichia coli. J. Bacteriol. 170: 1739-1745.
4. Brumell, J. H., and B. B. Finlay. 1999. Bacterial adherence, colonization, and invasion of mucosal surfaces, p. 3-17. In K. A. Brogden, J. A. Roth, T. B. Stanton, C. A. Bolin, F. C. Minion, and M. J. Wannemuehler (ed.), Virulence mechanisms of bacterial pathogenesis. American Society for Microbiology, Washington, D.C.
5. Butler, T. 2001. Effect of increased inoculum of Salmonella typhi on MIC of azithromycin and resultant growth characteristics. J. Antimicrob. Chemother. 48:903-906.
6. Butler, T. 2002. Reduction of MIC of azithromycin for Salmonella typhi and Staphylococcus aureus in broth exposed to previous growth of Salmonella typhi. J. Antimicrob. Chemother. 50:143-145.
7. Chart, H. 1994. Bacterial fractionation and membrane protein characterization, p. 1-10. In H. Chart (ed.), Methods in practical laboratory bacteriology. CRC Press, Inc., Boca Raton, Fla.
8. Cirillo, D. M., R. H. Valdivia, D. M. Monack, and S. Falkow. 1998. Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival. Mol. Microbiol. 30:175-188.
9. Darwin, K. H., and V. L. Miller. 1999. Molecular basis of the interaction of Salmonella with the intestinal mucosa. Clin. Microbiol. Rev. 12:405-428.
10. Duran, J. M., and G. W. Amsden. 2000. Azithromycin: indications for the future? Expert Opin. Pharmacother. 1:489-505.
11. 28) regulates the expression of Salmonella genes associated with the centisome 63 type III secretion system. Infect. Immun. 68:2735-2743.
12. Frenck, R. W., Jr., I. Nakhla, Y. Sultan, S. B. Bassily, Y. F. Girgis, J. David, T. C. Butler, N. I. Girgis, and M. Morsy. 2000. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin. Infect. Dis. 31:1134-1138.
13. Galan, J. E., and D. Zhou. 2000. Striking a balance: modulation of the actin cytoskeleton by Salmonella. Proc. Natl. Acad. Sci. USA 97:8754-8761.
14. Gulig, P. A. 1996. Pathogenesis of systemic diseases, p. 2774-2787. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. American Society for Microbiology, Washington, D.C.
15. Gulig, P. A., and R. Curtiss III. 1987. Plasmid-associated virulence of Salmonella typhimurium. Infect. Immun. 55:2891-2901.
16. Gulig, P. A., and T. J. Doyle. 1993. The Salmonella typhimurium virulence plasmid increases the growth rate of salmonellae in mice. Infect. Immun. 61:504-511.
17. Horii, T., M. Morita, H. Muramatsu, Y. Muranaka, T. Kanno, and M. Maekawa. 2003. Effects of mupirocin at subinhibitory concentrations on flagella formation in Pseudomonas aeruginosa and Proteus mirabilis. J. Antimicrob. Chemother. 51:1175-1179.
18. Hueck, C. J. 1998. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol. Mol. Biol. Rev. 62:379-433.
19. Japan Society of Chemotherapy. 1981. Method of MIC determination. Chemotherapy 29:76-79.
20. Kawamura-Sato, K., Y. Iinuma, T. Hasegawa, T. Horii, T. Yamashino, and M. Ohta. 2000. Effect of subinhibitory concentrations of macrolides on expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis. Antimicrob. Agents Chemother. 44:2869-2872.
21. Kawamura-Sato, K., Y. Iinuma, T. Hasegawa, T. Yamashino, and M. Ohta. 2001. Postantibiotic suppression effect of macrolides on the expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis. J. Infect. Chemother. 7:51-54.
22. Kim, W., T. Killam, V. Sood, and M. G. Surette. 2003. Swarm-cell differentiation in Salmonella enterica serovar Typhimurium results in elevated resistance to multiple antibiotics. J. Bacteriol. 185:3111-3117.
23. Kim, W., and M. G. Surette. 2003. Swarming populations of Salmonella represent a unique physiological state coupled to multiple mechanisms of antibiotic resistance. Biol. Proc. Online 5:189-196.
24. Komoriya, K., N. Shibano, T. Higano, N. Azuma, S. Yamaguchi., and S. I. Aizawa. 1999. Flagellar proteins and type III-exported virulence factors are the predominant proteins secreted into the culture media of Salmonella typhimurium. Mol. Microbiol. 34:767-779.
25. Kubori, T., Y. Matsushima, D. Nakamura, J. Uralil, M. Lara-Tejero, A. Sukhan, J. E. Galan, and S. I. Aizawa. 1998. Supramolecular structure of the Salmonella typhimurium type III protein secretion system. Science 280:602-605.
26. Kutsukake, K., Y. Ohya, and T. Iino. 1990. Transcriptional analysis of the flagellar regulon of Salmonella typhimurium. J. Bacteriol. 172:741-747.
27. Kutsukake, K., Y. Ohya, S. Yamaguchi, and T. Iino. 1988. Operon structure of flagellar genes in Salmonella typhimurium. Mol. Gen. Genet. 214:11-15.
28. Lee, A. C. 2003. Type III secretion systems of enteric bacterial pathogens, p. 403-422. In G. A. Hecht (ed.), Microbial pathogenesis and the intestinal epithelial cell. American Society for Microbiology, Washington, D.C.
29. Liu, X., and P. Matsumura. 1994. The FlhD/FlhC complex, a transcriptional activator of the Escherichia coli flagellar class II operons. J. Bacteriol. 176: 7345-7351.
30. Macnab, R. M. 1996. Flagella and motility, p. 123-145. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed. American Society for Microbiology, Washington, D.C.
31. Matsui, H., A. Abe, S. Suzuki, M. Kijima, Y. Tamura, M. Nakamiira, K. Kawahara, and H. Danbara. 1993. Molecular mechanism of the regulation of expression of plasmid-encoded mouse bacteremia (mba) genes in Salmonella serovar Choleraesuis. Mol. Gen. Genet. 236:219-226.
32. Matsui, H., M. Eguchi, and Y. Kikuchi. 2000. Use of confocal microscopy to detect Salmonella typhimurium within host cells associated with Spv-mediated intracellular proliferation. Microb. Pathog. 29:53-59.
33. Matsui, H., T. Kawakami, S. Ishikawa, H. Danbara, and P. A. Gulig. 2000. Constitutively expressed phoP inhibits mouse-virulence of Salmonella typhimurium in an Spv-dependent manner. Microbiol. Immunol. 44:447-454.
34. Matsui, H., M. Suzuki, Y. Isshiki, C. Kodama, M. Eguchi, Y. Kikuchi, K. Motokawa, A. Takaya, T. Tomoyasu, and T. Yamamoto. 2003. Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar Typhimurium. Infect. Immun. 71:30-39.
35. Maurin, M., and D. Raoult. 1997. Intracellular organisms. Int. J. Antimicrob. Agents 9:61-70.
36. Miller, M. B., and B. L. Bassler. 2001. Quorum sensing in bacteria. Annu. Rev. Microbiol. 55:165-199.
37. Molinari, G., P. Paglia, and G. C. Schito. 1992. Inhibition of motility of Pseudomonas aeruginosa and Proteus mirabilis by subinhibitory concentrations of azithromycin. Eur. J. Clin. Microbiol. Infect. Dis. 11:469-471.
38. Nakamiira, A., K. Nakazawa, I. Miyakozawa, S. Mizukoshi, K. Tsurubuchi, M. Nakagawa, K. O'Hara, and T. Sawai. 2000. Macrolide esterase-producing Escherichia coli clinically isolated in Japan. J. Antibiot. (Tokyo) 53:516-524.
39. Ochman, H., F. C. Soncini, F. Solomon, and E. A. Groisman. 1996. Identification of a pathogenicity island required for Salmonella survival in host cells. Proc. Natl. Acad. Sci. USA 93:7800-7804.
40. Ohl, M. E., and S. I. Miller. 2001. Salmonella: a model for bacterial pathogenesis. Annu. Rev. Med. 52:259-274.
41. Posho, L., L. Delbos-Bocage, D. Gueylard, R. Farinotti, and C. Carbon. 1998. Effects of Salmonella typhimurinm infection and ofloxacin treatment on glucose and glutamine metabolism in Caco-2/TC-7 cells. Antimicrob. Agents Chemother. 42:2950-2955.
42. Rakita, R. M., K. Jacques-Palaz, and B. E. Murray. 1994. Intracellular activity of azithromycin against bacterial enteric pathogens. Antimicrob. Agents Chemother. 38:1915-1921.
43. Scherer, C. A., and S. I. Miller. 2001. Molecular pathogenesis of Salmonella, p. 265-333. In E. A. Groisman (ed.), Principles of bacterial pathogenesis. Academic Press, San Diego, Calif.
44. Schmidt, H., and M. Hensel. 2004. Pathogenicity islands in bacterial pathogenesis. Clin. Microbiol. Rev. 17:14-56.
45. Schoni, M. H. 2003. Macrolide antibiotic therapy in patients with cystic fibrosis. Swiss Med. Wkly. 133:297-301.
46. Stock, I., and B. Wiedemann. 2000. Natural antibiotic susceptibility of Salmonella enterica strains. Int. J. Antimicrob. Agents 16:211-217.
47. Takaya, A., M. Suzuki, H. Matsui, T. Tomoyasu, H. Sashinami, A. Nakane, and T. Yamamoto. 2003. Lon, a stress-induced ATP-dependent protease, is critically important for systemic Salmonella enierica serovar Typhimurium infection of mice. Infect. Immun. 71:690-696.
48. Takaya, A., T. Tomoyasu, A. Tokumitsu, M. Morioka, and T. Yamamoto. 2002. The ATP-dependent Lon protease of Salmonella enterica serovar Typhimurium regulates invasion and expression of genes carried on Salmonella pathogenicity island 1. J. Bacteriol. 184:224-232.
49. Tateda, K., R. Comte, J. C. Pechere, T. Kohler, K. Yamaguchi, and C. Van Delden. 2001. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 45:1930-1933.
50. Tomoyasu, T., T. Ohkishi, Y. Ukyo, A. Tokumitsu, A. Takaya, M. Suzuki, K. Sekiya, H. Matsui, K. Kutsukake, and T. Yamamoto. 2002. The ClpXP ATP-dependent protease regulates flagellum synthesis in Salmonella enterica serovar Typhimurium. J. Bacteriol. 184:645-653.
51. Treadway, G. 2001. Azithromycin: a new 15-membered macrolide. Jpn. J. Antibiot. 54:70-76.
52. Walsh, C. 2003. Antibiotics that block bacterial protein synthesis, p. 51-70. In C. Walsh (ed.), Antibiotics actions, origins, resistance. American Society for Microbiology, Washington D.C.
53. Walsh, C. 2003. Antibiotics resistance by replacement or modification of the antibiotic target, p. 143-155. In C. Walsh (ed.), Antibiotics actions, origins, resistance. American Society for Microbiology, Washington, D.C.
54. Wilson, J. A., T. J. Doyle, and P. A. Gulig. 1997. Exponential-phase expression of spvA of the Salmonella typhimurium virulence plasmid: induction in intracellular salts medium and intracellularly in mice and cultured mammalian cells. Microbiology 143:3827-3839.
55. Xavier, K. B., and B. L. Bassler. 2003. LuxS quorum sensing: more than just a numbers game. Curr. Opin. Microbiol. 6:191-197.
56. Yamanaka, K., T. Ogura, H. Niki, and S. Hiraga. 1992. Identification and characterization of the smbA gene, a suppressor of the mukB null mutant of Escherichia coli. J. Bacteriol. 174:7517-7526.